Gemcitabine and cisplatin for advanced urothelial carcinomas: the Ehime University Hospital experience

被引：0
|
作者：
Akira Ozawa
Nozomu Tanji
Tatsumasa Ochi
Yutaka Yanagihara
Tadahiko Kikugawa
Akiko Yamaguchi
Tetsuhiro Ikeda
Kenji Shimamoto
Katsunori Aoki
Akihiko Toshino
Masayoshi Yokoyama
机构：
[1] Ehime University Graduate School of Medicine,Department of Urology
来源：
International Journal of Clinical Oncology | 2007年 / 12卷
关键词：
Gemcitabine; Cisplatin; Metastatic urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：279 / 283
页数：4
相关论文
共 50 条
  • [41] Fluoropyrimidines plus Cisplatin versus Gemcitabine/Gemcitabine plus Cisplatin in Locally Advanced and Metastatic Biliary Tract Carcinoma - A Retrospective Study
    Croitoru, Adina
    Gramaticu, Julia
    Dinu, Ioana
    Gheorghe, Liana
    Alexandrescu, Sorin
    Buica, Florina
    Luca, Ioana
    Becheanu, Gabriel
    Herlea, Vlad
    Simionov, Iulia
    Hrehoret, Doina
    Lupescu, Ioana
    Popescu, Irinel
    Diculescu, Mircea
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2012, 21 (03) : 277 - 284
  • [42] Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer
    J. R. Kroep
    E. F. Smit
    G. Giaccone
    K. Van der Born
    J. H. Beijnen
    C. J. Van Groeningen
    W. J. F. Van der Vijgh
    P. E. Postmus
    H. M. Pinedo
    G. J. Peters
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 509 - 516
  • [43] Safety of same-day administration of gemcitabine plus cisplatin chemotherapy for urothelial carcinoma
    Tsuru, Ibuki
    Niimi, Fusako
    Honda, Sachi
    Azuma, Takeshi
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (03)
  • [44] Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
    Fairey, Adrian S.
    Daneshmand, Siamak
    Quinn, David
    Dorff, Tanya
    Dorin, Ryan
    Lieskovsky, Gary
    Schuckman, Anne
    Cai, Jie
    Miranda, Gus
    Skinner, Eila C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1737 - 1743
  • [45] Cost-effectiveness of nivolumab plus gemcitabine-cisplatin as first-line treatment for advanced urothelial carcinoma in China and the United States
    Xiang, Guiyuan
    Huang, Yueyue
    Gan, Lanlan
    Wang, Linning
    Ding, Yunqi
    Wu, Yuanlin
    Xing, Haiyan
    Liu, Yao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [46] Is a combination of gemcitabine and docetaxel effective in advanced urothelial carcinoma?
    Stöckle, M
    Lehmann, J
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (09): : 420 - 421
  • [47] Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer
    De Lange, SM
    van Groeningen, CJ
    Kroep, JR
    Van Bochove, A
    Snijders, JF
    Peters, GJ
    Pinedo, HM
    Giaccone, G
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 484 - 488
  • [48] Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer
    López-Vivanco, G
    Viteri, A
    Barceló, R
    Muñoz, A
    Rubio, I
    Mañé, JM
    Fuente, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (05): : 501 - 507
  • [49] A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
    Basil F. El-Rayes
    Mark M. Zalupski
    Anthony F. Shields
    Ann Marie Ferris
    Ulka Vaishampayan
    Lance K. Heilbrun
    Raghu Venkatramanamoorthy
    Volkan Adsay
    Philip A. Philip
    Investigational New Drugs, 2005, 23 : 583 - 590
  • [50] Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma?
    Jacobs, Andrew
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (08): : 424 - 425
12345